Administrative Contact
Ms. J. Knapp
[email protected]
After completing undergraduate studies in biochemistry at SUNY College at Geneseo, Dr. Lou received his M.D. and Ph.D. degrees (Microbiology and Immunology) from SUNY Upstate Medical University in 2004. He performed his residency training in Internal Medicine at Duke University Medical Center and then subsequently completed his Medical Oncology and Hematology fellowship at the Memorial Sloan-Kettering Cancer Center in 2010. He also completed an additional fellowship in Neuro-Oncology at the Preston Robert Tisch Brain Tumor Center at Duke. Dr. Lou, a diplomate of the American Board of Internal Medicine, is board certified in Medical Oncology and Internal Medicine. In addition he is also board certified in Neuro-Oncology through the United Council for Neurologic Subspecialties. He joined the faculty in the Division of Hematology, Oncology and Transplantation in 2011 and is a member of the Masonic Cancer Center, University of Minnesota. Care Philosophy New Patients If you are scheduled or interested in scheduling a clinic consultation with Dr. Lou, click here for more information and a welcome from Dr. Lou. Tips to be a Great Patient Advocate Dr. Lou's interview with Caringbridge.org
Role of tunneling nanotubes in intercellular communication and pathophysiology of cancer. Biomarkers of drug resistance in cancer Genomic markers of exceptional response or non-response to drug therapy in solid tumor malignancies (colorectal cancer and malignant brain tumors)
Dr. Lou served on the American Society of Clinical Oncology (ASCO) Scientific Committee for GI Cancers (2012-15), and more recently on the ASCO Scientific Committee for Developmental Therapeutics Tumor Biology Track (2022-25; Track Leader 2023-24). He also serves on the Education Committee (Co-Chair 2023-24, Chair 2024-25) and Programming Committee (2025-26) for the North American Neuroendocrine Tumor Society (NANETS), and as Deputy Editor for the Cell Press journal Molecular Therapy Oncology. From 2019-2023, he served as Medical Director of the University of Minnesota Masonic Cancer Center's Clinical Trials Office-Solid Tumor Unit.
Appendix Cancer; Neuroendocrine Tumors; Pancreatic Cancer; Esophageal Cancer; Gastric Cancer; Colorectal Cancer; Cancer Metastasis; Solid Tumor Metastasis to the Brain; Brain Tumors